US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic ... pharmabiz.com “Sustaining appropriate levels of cysteamine in the body is the key to maintaining organ function and lowering the likelihood of kidney transplantation. Most patients don't take their cystinosis medication consistently as a result of severe stomach ... |
